Effect of ICE regimen in treatment of relapsed and refractory non-Hodgkin's lymphoma
Yongzhong Liu, Jiewen Peng, Jing-huang He, Han‐lin Liang, Zhao-feng Yin
Abstract
Yongzhong Liu, Jiewen Peng, Jing-huang He, Han‐lin Liang, Zhao-feng Yin
Abstract
Objective To evaluate the short-term effect and side effects of ICE regimen treating the patients with relapsed and refractory non-Hodgkin's lymphoma(NHL). Methods Twenty-five patients with relapsed and refractory NHL were treated with ICE regimen. Treatment was repeated every 3 weeks. Results The total effective rate was 76.0% for 25 patients,The response rate(PR) was 60.0%. The main side effects were marrow suppression including of leucopenia and thrombocytopenia,no patients dead for toxic reactions of chemotherapy. Conclusion ICE regimen was a safe and effective salvage regimen for the patients with relapsed and refractory NHL. Key words: Lymphoma, non-Hodgkin; Chemotherapy
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the short-term effect and side effects of ICE regimen treating the patients with relapsed and refractory non-Hodgkin's lymphoma(NHL). Methods Twenty-five patients with relapsed and refractory NHL were treated with ICE regimen. Treatment was repeated every 3 weeks. Results The total effective rate was 76.0% for 25 patients,The response rate(PR) was 60.0%. The main side effects were marrow suppression including of leucopenia and thrombocytopenia,no patients dead for toxic reactions of chemotherapy. Conclusion ICE regimen was a safe and effective salvage regimen for the patients with relapsed and refractory NHL. Key words: Lymphoma, non-Hodgkin; Chemotherapy
Key concepts: Medicine, Regimen, Refractory (planetary science), Lymphoma, Chemotherapy, Internal medicine, Surgery, Gastroenterology